NEWSROOM

Kali-Extracts

KALY – Kali-Extracts Confirm Website Launch For RespRx CBD COPD Treatment Formulation Scheduled For Tomorrow

            Dallas, TX – Aug 22, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled website launch for tomorrow dedicated to the company’s recently announced RespRx CBD Formulation for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The RespRx website to be published Friday, August 23rd, 2019, will include details on KALY’s recent patent and...

read more

KALY – Kali-Extracts Realizes 250% Revenue Growth From New Cannabis Business With Even More Dramatic Growth Anticipated In Second Half Of 2019

KALY 1st Six Months 2019 Revenue Is $165,000 Compared To $46,000 Last Year KALY Also Reported $70,000 Operating Net Income 1st Six Months 2019 250% Revenue Growth Results From Q4 2018 Cannabis Business Acquired Q4 2018 KALY Owns And Operates Patented Cannabis Extraction Process And Has Filed For A Second Patent On A New Biopharmaceutical CBD Formulation Hemp Farming CBD Extraction Contracts Anticipated To Result In Even More Dramatic Revenue Growth In Second Half Of 2019 KALY Plans To...

read more

KALY – Kali-Extracts Files Patent Application For CBD Formulation To Treat COPD Derived From Existing Kali-Extracts Patented Cannabis Extraction Process

  Dallas, TX – August 21, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company has filed a new patent application specifically on its formulation for symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions.  The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company’s existing patented...

read more

KALY – Kali-Extracts Announces RespRx CBD Formulation For Symptoms Associated With COPD – A $14 Billion Market Opportunity

KALY Develops COPD Treatment CBD Formulation from Its Patented Extraction Process KALY Files New Patent Application on Its CBD Formulation for the Treatment of COPD KALY Files Trademark Registration on RespRx Brand Name for COPD Treatment Market for COPD Treatment Anticipated to Reach $14 Billion KALY to File Up-To-Date Corporate Financials on Thursday This Week KALY to Publish RespRx Website with Patent and Trademark Details on Friday Dallas, TX – Aug 20, 2019 -- -- Kali-Extracts, Inc. (Kali,...

read more

KALY – Kali-Extracts Confirms Corporate Up-To-Date Financials Scheduled For Publication This Thursday And RespRx Website Coming Friday

Dallas, TX – Aug 20, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company intends to publish up-to-date corporate financials on Thursday, August 22nd.  The company also plans to publish a website on Friday, August 23rd, dedicated to its new CBD formulation, RespRx, for treating symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions.  The KALY management commitments to...

read more

KALY – Kali-Extracts CEO Updated On Latest Cannabis Extract Biopharmaceutical Developments Scheduled Next Week, August 20, 2019

  Dallas, TX – Aug 15, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a scheduled CEO update to be published next week on Tuesday, August 20th, 2019 to provide shareholders with the latest updates on the company’s Cannabis Extract Biopharmaceutical developments.  KALY owns and operates a US Patented Cannabis Extraction Process utilized primarily on discovering, developing and commercializing novel therapeutics from a proprietary...

read more

KALY – Kali-Extracts CEO Reminds Shareholders They Own Stock In A Cannabis Biopharmaceutical Company With GW Pharmaceuticals Potential

  Dallas, TX – Aug 16, 2019 (GLOBE NEWSWIRE) -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled CEO update to be published next week on Tuesday, August 20th, 2019 to provide shareholders with the latest updates on the company’s Cannabis Extract Biopharmaceutical developments. “KALY is executing on a number of business lines from straight commercial CBD extraction from client hemp crops to the infusion of CBD into various consumer...

read more

KALY – Kali-Extracts Confirms Cannabis Biopharmaceutical Update Targeting $170 Billion Market Scheduled For Release Tomorrow

Dallas, TX – Aug 19, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled CEO update to be published tomorrow on Tuesday, August 20th, 2019 to provide shareholders with the latest updates on the company’s Cannabis Extract Biopharmaceutical developments.  The company is currently developing Cannabis Extract Biopharmaceutical Therapies targeting $170 billion in market potential: Chronic Obstructive Pulmonary Disease (COPD) - The...

read more

KALY – Kali- Extracts Revenue Ramp Anticipated With Coming Hemp Harvest

Dallas, TX – Aug 13, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company anticipates a dramatic revenue increase in the second half of 2019 in conjunction with the hemp extraction contracts announced earlier this summer.  So far, KALY has announced two contracts to extract CBD from hemp worth a total combined potential of $15 million.  Management has set a target to sign $20 million in CBD extraction contracts this year. ...

read more

PURA and KALY Add CBD Infused Tea To New Beverage Partnerships

Dallas, Texas – August 6, 2019 -- – Puration, Inc. (USOTC: PURA) (”PURA”) and Kali-Extracts (aka Kali, Inc.) (USOTC: KALY) (“KALY”)  today confirmed adding CBD infused tea to its new line of CBD beverage partnerships.  Last week, PURA and KALY published a management presentation to provide shareholders with more details on PURA’s recently implemented program to introduce CBD infused versions of existing third-party beverages.  PURA has recently announced plans to introduce a CBD infused beer...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »